Diala Ezzeddine Email

Co-founder & COO . Differentiated Therapeutics

San Diego, San Diego

Location

LinkedIn

Current Roles

Employees:
9
Revenue:
$697.5k
About
Differentiated Therapeutics (DXTX) has built the first end-to-end discovery engine for Targeted Protein Degradation (TPD) which drives the discovery and optimization of novel protein degraders designed to eliminate the genetically defined drivers of disease
Differentiated Therapeutics Address
N/A
San Diego, San Diego
Differentiated Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.